Search research articles
Contact Us
Filters
Showing results (161-170 of 303) with videos related to
Page
of 31
Sort By:
JAMA Neurology
|
August 27, 2019
Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D
Alvaro San-Juan-Rodriguez, Chester B Good, Rock A Heyman, et al.
Military Medicine
|
February 7, 2008
Determinants of hormone therapy discontinuation among female veterans nationally
Sally G Haskell, Bevanne Bean-Mayberry, Joseph L Goulet, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 25, 2022
Trends in add-on medications following metformin monotherapy for type 2 diabetes
Elizabeth Cs Swart, Lynn M Neilson, Kiraat D Munshi, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 25, 2022
Comparison of real-world clinical and economic outcomes in patients receiving oral anticoagulants: A retrospective claims analysis
Cameron Karnick, Ashley Modany, Molly McGraw, et al.
Psychopharmacology Bulletin
|
November 17, 2007
Determinants of complementary and alternative medicine use by patients with bipolar disorder
Amy M Kilbourne, Laurel A Copeland, John E Zeber, et al.
Journal of Managed Care & Specialty Pharmacy
|
August 30, 2025
Impact of a real-time prescription benefit on adherence and utilization of low-cost prescription alternatives for members new to diabetes treatment
Elizabeth C S Swart, Jennifer L Nguyen, Samuel K Peasah, et al.
American Journal of Public Health
|
March 3, 2007
Symptom expression in coronary heart disease and revascularization recommendations for black and white patients
Marilyn Hravnak, Jeff Whittle, Mary E Kelley, et al.
Gut
|
September 29, 2006
Rate and predictors of treatment prescription for hepatitis C
Adeel A Butt, Amy C Justice, Melissa Skanderson, et al.
The American Journal of Managed Care
|
December 6, 2013
FDA warning and removal of rosiglitazone from VA national formulary
Sherrie E Aspinall, Xinhua Zhao, Chester B Good, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
January 11, 2022
Impact of the COVID-19 pandemic on new starts to oral oncology medications in the US
Lynn Neilson, Monal Kohli, Kiraat D Munshi, et al.
Page
of 31
Search research articles
Search
Showing results (161-170 of 303) with videos related to
Sort By:
Page
of 31
JAMA Neurology
|
August 27, 2019
Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D
Alvaro San-Juan-Rodriguez, Chester B Good, Rock A Heyman, et al.
Military Medicine
|
February 7, 2008
Determinants of hormone therapy discontinuation among female veterans nationally
Sally G Haskell, Bevanne Bean-Mayberry, Joseph L Goulet, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 25, 2022
Trends in add-on medications following metformin monotherapy for type 2 diabetes
Elizabeth Cs Swart, Lynn M Neilson, Kiraat D Munshi, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 25, 2022
Comparison of real-world clinical and economic outcomes in patients receiving oral anticoagulants: A retrospective claims analysis
Cameron Karnick, Ashley Modany, Molly McGraw, et al.
Psychopharmacology Bulletin
|
November 17, 2007
Determinants of complementary and alternative medicine use by patients with bipolar disorder
Amy M Kilbourne, Laurel A Copeland, John E Zeber, et al.
Journal of Managed Care & Specialty Pharmacy
|
August 30, 2025
Impact of a real-time prescription benefit on adherence and utilization of low-cost prescription alternatives for members new to diabetes treatment
Elizabeth C S Swart, Jennifer L Nguyen, Samuel K Peasah, et al.
American Journal of Public Health
|
March 3, 2007
Symptom expression in coronary heart disease and revascularization recommendations for black and white patients
Marilyn Hravnak, Jeff Whittle, Mary E Kelley, et al.
Gut
|
September 29, 2006
Rate and predictors of treatment prescription for hepatitis C
Adeel A Butt, Amy C Justice, Melissa Skanderson, et al.
The American Journal of Managed Care
|
December 6, 2013
FDA warning and removal of rosiglitazone from VA national formulary
Sherrie E Aspinall, Xinhua Zhao, Chester B Good, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
January 11, 2022
Impact of the COVID-19 pandemic on new starts to oral oncology medications in the US
Lynn Neilson, Monal Kohli, Kiraat D Munshi, et al.
Page
of 31